Ken Herrmann’s “Buy‑Low, Sell‑High” Play: Aktis Oncology Insider Traded 3,506 Shares at $0.08, Then Dumped 1,350 at $24.56 in One Day – Market Reacts?
Aktis Insider Moves: Ken Herrmann buys at $0.08, sells near $25, signaling confidence in its 225Ac pipeline and potential rebound.
3 minutes to read